Moreover, another recent report presented evidence that C/EBPα promotes NASH and hepatocellular carcinoma via activation of hyaluronan mediated motility receptor (HMMR) by binding to its promoter.27 Here, CEBPA is linked to metabolic dysfunction-associated steatohepatitis.